HIV-1 genetic variation resulting in the development of new quasispecies continues to be encountered in the peripheral blood of well-suppressed patients

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Dampier, Will ^a,b   Nonnemacher, Michael R ^a   Mell, Joshua ^a   Earl, Joshua ^a   Ehrlich, Garth D ^a   Pirrone, Vanessa ^a   Aiamkitsumrit, Benjamas ^a   Zhong, Wen ^a   Kercher, Katherine ^a   Passic, Shendra ^a   Williams, Jean W ^a   Jacobson, Jeffrey M ^a   Wigdahl, Brian ^a,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS DNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; PERIPHERAL CIRCULATION; PHYLOGENETIC TREE; PHYLOGENY; SEXUAL TRANSMISSION; VIRUS GENOME; VIRUS LOAD; BLOOD; COHORT ANALYSIS; CYTOLOGY; DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84982124823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155382     Document Type: Article

References (48)

1. Pennings PS. HIV Drug Resistance: Problems and Perspectives. Infectious disease reports. 2013; 5 (Suppl 1):e5. doi: 10.4081/idr.2013.s1.e5 PMID: 24470969; PubMed Central PMCID: PMC3892620.
2. Quashie PK, Mesplede T, Wainberg MA. Evolution of HIV integrase resistance mutations. Curr Opin Infect Dis. 2013; 26(1):43-9. doi: 10.1097/QCO.0b013e32835ba81c PMID: 23242340.
3. Samikkannu T, Atluri VS, Arias AY, Rao KV, Mulet CT, Jayant RD, et al. HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders. Curr HIV Res. 2014; 12(6):397-405. PMID: 25613138.
4. Fields J, Dumaop W, Elueteri S, Campos S, Serger E, Trejo M, et al. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015; 35(5):1921-38. doi: 10.1523/JNEUROSCI.3207-14.2015 PMID: 25653352; PubMed Central PMCID: PMC4315828.
5. Krebs FC, Ross H, McAllister J, Wigdahl B. HIV-associated neurologic dysfunction. In HIV: Molecular mechanisms and Clinical Applications. In: Jeang KT, editor. Advances in Pharmacology. 492000. p. 315-85.
6. Wilhelm E, Bell B. Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency. Current opinion in virology. 2013; 3(4):380-6. doi: 10.1016/j.coviro.2013.06.006 PMID: 23827503.
7. Tedaldi EM, Minniti NL, Fischer T. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. BioMed research international. 2015; 2015:641913. doi: 10.1155/2015/641913 PMID: 25815329; PubMed Central PMCID: PMC4359826.
8. Wolfs TF, Zwart G, Bakker M, Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology. 1992; 189(1):103-10. PMID: 1376536.
9. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol. 1993; 67(6):3345-56. PMID: 8497055; PubMed Central PMCID: PMC237678.
10. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008; 105(21):7552-7. doi: 10.1073/pnas.0802203105 PMID: 18490657; PubMed Central PMCID: PMC2387184.
11. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009; 206(6):1273-89. doi: 10.1084/jem.20090378 PMID: 19487424; PubMed Central PMCID: PMC2715054.
12. Tsai L, Tasovski I, Leda AR, Chin MP, Cheng-Mayer C. The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection. Retrovirology. 2014; 11:22. doi: 10.1186/1742-4690-11-22 PMID: 24612462; PubMed Central PMCID: PMC3975242.
13. Gonzalez MW, DeVico AL, Lewis GK, Spouge JL. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission. J Virol. 2015; 89(7):3619-29. doi: 10.1128/JVI.03235-14 PMID: 25589663; PubMed Central PMCID: PMC4403421.
14. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995; 69(8):5087-94. PMID: 7541846; PubMed Central PMCID: PMC189326.
15. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, et al. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000; 288(5472):1789-96. PMID: 10846155.
16. Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev. 2012; 76(2):159-216. doi: 10.1128/MMBR.05023-11 PMID: 22688811; PubMed Central PMCID: PMC3372249.
17. Wargo AR, Kurath G. Viral fitness: definitions, measurement, and current insights. Current opinion in virology. 2012; 2(5):538-45. doi: 10.1016/j.coviro.2012.07.007 PMID: 22986085.
18. Nowak MA. Variability of HIV infections. J Theor Biol. 1992; 155(1):1-20. PMID: 1619947.
19. Shankarappa R, Gupta P, Learn GH Jr., Rodrigo AG, Rinaldo CR Jr., Gorry MC, et al. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology. 1998; 241(2):251-9. doi: 10.1006/viro.1997.8996 PMID: 9499799.
20. Briones C, Domingo E. Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications. AIDS Rev. 2008; 10(2):93-109. PMID: 18615120.
21. Churchill M, Nath A. Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS. 2013; 8(3):165-9. doi: 10.1097/COH.0b013e32835fc601 PMID: 23429501.
22. Kanmogne GD, Kennedy RC, Grammas P. Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses. 2001; 17(1):45-53. doi: 10.1089/088922201750056771 PMID: 11177382.
23. Nannini EC, Okhuysen PC. HIV1 and the gut in the era of highly active antiretroviral therapy. Current gastroenterology reports. 2002; 4(5):392-8. PMID: 12228041.
24. van der Sluis RM, Jeeninga RE, Berkhout B. Establishment and molecular mechanisms of HIV-1 latency in T cells. Current opinion in virology. 2013; 3(6):700-6. doi: 10.1016/j.coviro.2013.07.006 PMID: 23953324.
25. Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res. 2008; 6(5):388-400. Epub 2008/10/16. PMID: 18855649; PubMed Central PMCID: PMC2683678.
26. Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E. Reactivation of latent HIV by histone deacetylase inhibitors. Trends in microbiology. 2013; 21(6):277-85. doi: 10.1016/j.tim.2013.02.005 PMID: 23517573; PubMed Central PMCID: PMC3685471.
27. Ensoli B, Cafaro A, Monini P, Marcotullio S, Ensoli F. Challenges in HIV Vaccine Research for Treatment and Prevention. Frontiers in immunology. 2014; 5:417. doi: 10.3389/fimmu.2014.00417 PMID: 25250026; PubMed Central PMCID: PMC4157563.
28. Gu WG. Genome editing-based HIV therapies. Trends in biotechnology. 2015; 33(3):172-9. doi: 10.1016/j.tibtech.2014.12.006 PMID: 25600622.
29. Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, et al. Development of coselected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. J Neurovirol. 2011; 17(1):92-109. Epub 2011/01/13. doi: 10.1007/s13365-010-0014-1 PMID: 21225391; PubMed Central PMCID: PMC3057211.
30. Aiamkitsumrit B, Sullivan NT, Nonnemacher MR, Pirrone V, Wigdahl B. Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral Disease. Adv Virus Res. 2015; 93:257-311. doi: 10.1016/bs.aivir.2015.04.001 PMID: 26111588.
31. Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, et al. Bioinformatic analysis of HIV-1 entry and pathogenesis. Curr HIV Res. 2014; 12(2):132-61. PMID: 24862329; PubMed Central PMCID: PMC4382797.
32. Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, et al. Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences. PLoS One. 2014; 9(9):e107389. doi: 10.1371/journal.pone.0107389 PMID: 25265194; PubMed Central PMCID: PMC4180074.
33. Bouckaert R, Heled J, Kuhnert D, Vaughan T, Wu CH, Xie D, et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2014; 10(4):e1003537. doi: 10.1371/journal.pcbi.1003537 PMID: 24722319; PubMed Central PMCID: PMC3985171.
34. Bezemer D, Faria NR, Hassan A, Hamers RL, Mutua G, Anzala O, et al. HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya. AIDS Res Hum Retroviruses. 2014; 30(2):118-26. doi: 10.1089/AID.2013.0171 PMID: 23947948; PubMed Central PMCID: PMC3910480.
35. Kondo M, Lemey P, Sano T, Itoda I, Yoshimura Y, Sagara H, et al. Emergence in Japan of an HIV-1 variant associated with transmission among men who have sex with men (MSM) in China: first indication of the International Dissemination of the Chinese MSM lineage. J Virol. 2013; 87(10):5351-61. doi: 10.1128/JVI.02370-12 PMID: 23365432; PubMed Central PMCID: PMC3648132.
36. Josefsson L, von Stockenstrom S, Faria NR, Sinclair E, Bacchetti P, Killian M, et al. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A. 2013; 110(51):E4987-96. doi: 10.1073/pnas.1308313110 PMID: 24277811; PubMed Central PMCID: PMC3870728.
37. Ho SY, Shapiro B. Skyline-plot methods for estimating demographic history from nucleotide sequences. Molecular ecology resources. 2011; 11(3):423-34. doi: 10.1111/j.1755-0998.2011.02988.x PMID: 21481200.
38. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nature methods. 2012; 9(8):772. doi: 10.1038/nmeth.2109 PMID: 22847109.
39. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004; 32(5):1792-7. Epub 2004/03/23. doi: 10.1093/nar/gkh340 PMID: 15034147; PubMed Central PMCID: PMC390337.
40. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014; 30(9):1312-3. doi: 10.1093/bioinformatics/btu033 PMID: 24451623; PubMed Central PMCID: PMC3998144.
41. Sukumaran J, Holder MT. DendroPy: a Python library for phylogenetic computing. Bioinformatics. 2010; 26(12):1569-71. doi: 10.1093/bioinformatics/btq228 PMID: 20421198.
42. Verbeke G, Fieuws S, Molenberghs G, Davidian M. The analysis of multivariate longitudinal data: a review. Statistical methods in medical research. 2014; 23(1):42-59. doi: 10.1177/0962280212445834 PMID: 22523185; PubMed Central PMCID: PMC3404254.
43. Vider-Shalit T, Almani M, Sarid R, Louzoun Y. The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire. AIDS. 2009; 23(11):1311-8. doi: 10.1097/QAD.0b013e32832c492a PMID: 19550286.
44. Krakauer DC, Sasaki A. The greater than twofold cost of integration for retroviruses. Proc Biol Sci. 2006; 273(1590):1159-63. doi: 10.1098/rspb.2005.3322 PMID: 16600896; PubMed Central PMCID: PMC1560259.
45. Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Boni J, et al. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci U S A. 2008; 105(43):16725-30. doi: 10.1073/pnas.0804192105 PMID: 18936487; PubMed Central PMCID: PMC2575487.
46. Chun TW. Tracking replication-competent HIV reservoirs in infected individuals. Curr Opin HIV AIDS. 2013; 8(2):111-6. doi: 10.1097/COH.0b013e32835d6e1c PMID: 23380652.
47. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009; 323(5919):1304-7. doi: 10.1126/science.1165706 PMID: 19265012.
48. Richman DD. Introduction: challenges to finding a cure for HIV infection. Curr Opin HIV AIDS. 2011; 6(1):1-3. doi: 10.1097/COH.0b013e328340ffa6 PMID: 21242886; PubMed Central PMCID: PMC3077900.